Interventions for acute non-arteritic central retinal artery occlusion
- PMID: 19160204
- PMCID: PMC7081130
- DOI: 10.1002/14651858.CD001989.pub2
Interventions for acute non-arteritic central retinal artery occlusion
Update in
-
Interventions for acute non-arteritic central retinal artery occlusion.Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD001989. doi: 10.1002/14651858.CD001989.pub3. Cochrane Database Syst Rev. 2023. PMID: 36715340 Free PMC article.
Abstract
Background: Acute central retinal artery occlusion (CRAO) occurs as a sudden interruption of the blood supply to the retina and results in an almost complete loss of vision in the affected eye. There is no generally agreed treatment regimen although a number of therapeutic interventions have been proposed.
Objectives: The objective of this review was to examine the effects of treatments used for acute non-arteritic CRAO.
Search strategy: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library, Issue 3, 2008), MEDLINE (January 1966 to September 2008), EMBASE (January 1980 to September 2008) and the reference lists of relevant papers.
Selection criteria: We included randomised controlled trials (RCTs) only in which one treatment aimed to re-establish blood supply to the retina in people with acute CRAO was compared to another treatment.
Data collection and analysis: Two authors independently assessed the search results for relevant trials. Discrepancies were resolved by discussion.
Main results: We found two RCTs that met our inclusion criteria.
Authors' conclusions: The included studies in this review were small and from single centres. Neither study was completely clear about it's method of treatment allocation. One study described the use of pentoxifylline tablets (three 600 mg tablets daily) and the other the use of enhanced external counterpulsation (EECP) combined with haemodilution. Both studies indicated improved retinal perfusion in the non-control group but neither showed an improvement in vision. Large, well-designed RCTs are still required to establish the most effective treatment for acute CRAO. These studies should be looking at factors important to the patient i.e. improved vision with acceptable risk/side-effects.
Conflict of interest statement
None known.
Update of
-
Interventions for acute non-arteritic central retinal artery occlusion.Cochrane Database Syst Rev. 2002;(1):CD001989. doi: 10.1002/14651858.CD001989. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001989. doi: 10.1002/14651858.CD001989.pub2. PMID: 11869617 Updated.
References
References to studies included in this review
Incandela 2002 {published data only}
-
- Incandela L, Cesarone MR, Belcaro G, Steigerwalt R, Sanctis MT, Nicolaides AN, et al. Treatment of vascular retinal disease with pentoxifylline: a controlled, randomized trial. Angiology 2002;53(Suppl 1):S31‐4. - PubMed
Werner 2004 {published data only}
-
- Werner D, Michalk F, Harazny J, Hugo C, Daniel WG, Michelson G. Accelerated reperfusion of poorly perfused retinal areas in central retinal artery occlusion and branch retinal artery occlusion after a short treatment with enhanced external counterpulsation. Retina 2004;24(4):541‐7. - PubMed
References to studies excluded from this review
Arnold 2005 {published data only}
Atebara 1995 {published data only}
-
- Atebara NH, Brown GC, Cater J. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology 1995;102(12):2029‐34. - PubMed
Augsburger 1980 {published data only}
Drago 1982 {published data only}
-
- Drago F, Amico‐Roxas M, Matera M. Effects of L‐acetyl‐carnitine on the electroretinographic responses in patients with central retinal artery occlusion. Acta Therapeutica 1982;8(3):201‐8.
Gu 1999 {published data only}
-
- Gu WZ, Pu RX, Wang YG, Zhou LX, Dong L, Liu H. Analysis on the curative effects of GEQI oral in treatment of retinal artery occlusion. Aerospace Medicine 1999;10(2):64‐6.
Holschermann 2005 {published data only}
-
- Holschermann H, Krombach C, Jung A, Jacobi F, Tillmanns H, Weinand F. Treatment of acute central retinal artery occlusion with the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban. Thrombosis & Haemostasis 2005;94(3):684‐6. - PubMed
Iwafune 1980 {published data only}
-
- Iwafune Y, Yoshimoto H. Clinical use of pentoxifylline in haemorrhagic disorders of the retina. Pharmatherapeutica 1980;2(7):429‐38. - PubMed
Kattah 2002 {published data only}
-
- Kattah JC, Wang DZ, Reddy C. Intravenous Recombinant Tissue‐Type Plasminogen Activator Thrombolysis in Treatment of Central Retinal Artery Occlusion. Archives of Ophthalmology 2002;120(9):1234‐6. - PubMed
Neubauer 2000 {published data only}
-
- Neubauer AS, Mueller AJ, Schriever S, Gruterich M, Ulbig M, Kampik A. Minimally invasive therapy for clinically complete central retinal artery occlusion ‐ results and meta‐analysis of literature [Minimal invasive Therapie bei klinisch komplettem Zentralarterienverschluss ‐ eigene Ergebnisse und Literaturvergleich]. Klinische Monatsblatter fur Augenheilkunde 2000;217(1):30‐6. - PubMed
Pettersen 2005 {published data only}
-
- Pettersen JA, Hill MD, Demchuk AM, Morrish W, Hudon ME, Hu W, et al. Intra‐arterial thrombolysis for retinal artery occlusion: the Calgary experience. Canadian Journal of Neurological Sciences 2005;32(4):507‐11. - PubMed
Richard 1999 {published data only}
-
- Richard G, Lerche RC, Knospe V, Zeumer H. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology 1999;106(4):768‐73. - PubMed
Rumelt 1999 {published data only}
-
- Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. American Journal of Ophthalmology 1999;128(6):733‐8. - PubMed
Schmidt 1992 {published data only}
-
- Schmidt D, Schumacher M, Wakhloo AK. Microcatheter urokinase infusion in central retinal artery occlusion. American Journal of Ophthalmology 1992;113(4):429‐34. - PubMed
Schumacher 1993 {published data only}
-
- Schumacher M, Schmidt D, Wakhloo AK. Intra‐arterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology 1993;35(8):600‐5. - PubMed
Weber 1998 {published data only}
-
- Weber J, Remonda L, Mattle HP, Koerner U, Baumgartner RW, Sturzenegger M, et al. Selective intra‐arterial fibrinolysis of acute central retinal artery occlusion. Stroke 1998;29(10):2076‐9. - PubMed
Additional references
Arora 1999
-
- Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, et al. The multicenter study of enhanced external counterpulsation (MUST‐EECP): effect of EECP on exercise‐induced myocardial ischemia and anginal episodes. Journal of the American College of Cardiology 1999;33(7):1833‐40. - PubMed
Bath 2004
-
- Bath PMW, Bath‐Hextall FJ. Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2004, Issue 3. [Art. No.: CD000162. DOI: 10.1002/14651858.CD000162.pub2] - PubMed
Beatty 2000
Brown 1994
-
- Brown GC. Retinal arterial obstructive disease. In: Ryan SJ editor(s). Retina. 2nd Edition. Philadelphia: CV Mosby Co, 1994:1361‐77.
Deutsch 1983
-
- Deutsch TA, Read JS, Ernest JT, Goldstick TK. Effects of oxygen and carbon dioxide on the retinal vasculature in humans. Archives of Ophthalmology 1983;101(8):1278‐80. - PubMed
Feltgen 2006
-
- Feltgen N, Neubauer A, Jurklies B, Schmoor C, Schmidt D, Wanke J, et al. Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1. Graefes Archive for Clinical and Experimental Ophthalmology 2006;244(8):950‐6. - PubMed
Ffytche 1974
-
- Ffytche TJ. A rationalization of treatment of central retinal artery occlusion. Transactions of the Ophthalmological Societies of the United Kingdom 1974;94(2):468‐79. - PubMed
Frampton 1995
-
- Frampton JE, Brogden RN. Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders. Drugs Aging 1995;7(6):480‐503. - PubMed
Glanville 2006
Harino 1995
Harvey 2000
-
- Harvey PA, Winder S, Talbot JF. Trabeculectomy for central retinal artery occlusion. Eye 2000;14(Pt 2):256‐7. - PubMed
Hausmann 1991
Hayreh 1980
-
- Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980;87(1):75‐8. - PubMed
Higgins 2008
-
- Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Kieswetter 1983
-
- Kieswetter H, Korber N, Jung F, Reim M. Rheologic findings in patients with acute central retinal artery occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology 1983;220(2):92‐5. - PubMed
Manchanda 2007
-
- Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. Journal of the American College of Cardiology 2007;50(16):1523‐31. - PubMed
Pettersson 2006
Rassam 1993
-
- Rassam SM, Patel V, Kohner EM. The effect of acetazolamide on the retinal circulation. Eye 1993;7(Pt 5):697‐702. - PubMed
Sandercock 2003
Schmetterer 1996
-
- Schmetterer L, Lexer F, Findl O, Graselli U, Eichler HG, Wolzt M. The effect of inhalation of different mixtures of O2 and CO2 on ocular fundus pulsations. Experimental Eye Research 1996;63(4):351‐5. - PubMed
Wardlaw 2007
-
- Wardlaw JM, Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2003, Issue 3. [Art. No.: CD000213. DOI: 10.1002/14651858.CD000213] - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
